Belén Blanco

Johnson & Johnson (United States) — United States

Medicine · Health Sciences

24h-index2.1kcitations110works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(54), HER2/EGFR in Cancer Research(43), Radiopharmaceutical Chemistry and Applications(41), CAR-T cell therapy research(31), Hematopoietic Stem Cell Transplantation(11)

Publications110 total

mRNA-engineered T lymphocytes secreting bispecific T cell engagers with therapeutic potential in solid tumors
Frontiers in Immunology·2025Open Access
Simultaneous secretion of a PD-L1 x 4-1BB bispecific antibody improves antileukemic efficacy of STAb-T cells secreting a CD19-specific T-cell engager
OncoImmunology·2025· 1 citedOpen Access
Advancing CAR-T cell therapy: Insights into patient biology, leukapheresis, and cryopreservation
Molecular Therapy·2025· 1 citedOpen Access
Generation and functional evaluation of STAb-T cells
Methods in cell biology·2025
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression
Journal for ImmunoTherapy of Cancer·2025· 4 citedOpen Access
CD4 <sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
OncoImmunology·2024· 7 citedOpen Access
CD4 <sup>+</sup> tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
2024Open Access
Effect of CD22-directed CAR-T cells secreting anti-CD19 T cell engagers on control of leukemia progression compared to tandem anti-CD19/CD22 CAR-T cells.
Journal of Clinical Oncology·2024· 2 cited
Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations
Frontiers in Immunology·2024· 12 citedOpen Access
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
Science Translational Medicine·2024· 28 cited
2250P Exploring tumor microenvironment in lung cancer through patient-derived 3D models
Annals of Oncology·2023Open Access
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
OncoImmunology·2023· 15 citedOpen Access
Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023Open Access
Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023Open Access
Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023Open Access
Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
2023Open Access
Data from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023Open Access
Figure S11 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023Open Access
Figure S10 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023Open Access
Figure S8 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Luis Álvarez‐Vallina(22), Jesús F. San Miguel(15), Josè Antonio Pérez-Simón(13), Carmen Domínguez-Alonso(12), Laura Sanz(12), Ángel Ramírez-Fernández(12), Consuelo del Cañizo(11), Fermín Sánchez‐Guijo(10), Marta Compte(10), Laura Díez-Alonso(9), Luís I. Sánchez-Abarca(8), Antonio Tapia‐Galisteo(8), Oana Hangiu(8), Soraya Carrancio(7), Seandean L. Harwood(7), Ainhoa Erce-Llamazares(7), Anaïs Jiménez-Reinoso(7), Daniel Nehme-Álvarez(7), Francisco J. Blanco(7), José Luis Rodríguez‐­Peralto(7)